Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Epstein

Showing results (471-480 of 1,865) with videos related to

Pageof 187
Sort By:
The New England Journal of Medicine|October 24, 2002
A series on patient safetyLucian Leape, Arnold M Epstein, Mary Beth Hamel
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 2, 2011
Disseminated malignancies masquerading as cardiovascular implantable electronic devices infectionsPipin Kojodjojo, Roy M John, Laurence M Epstein
Postgraduate Medicine|February 26, 2000
Hypertension in patients with diabetes. Why is aggressive treatment essential?G Bakris, J Sowers, M Epstein, et al.
Hypertension (Dallas, Tex. : 1979)|April 17, 2001
Diabetes, hypertension, and cardiovascular disease: an updateJ R Sowers, M Epstein, E D Frohlich
Biochemistry|November 25, 1980
Calorimetric studies of ligand-induced modulation of calcium adenosine 5'-triphosphatase from sarcoplasmic reticulumM Epstein, Y Kuriki, R Biltonen, et al.
The American Journal of Medicine|August 1, 1984
Physician beliefs, attitudes, and prescribing behavior for anti-inflammatory drugsA M Epstein, J L Read, R Winickoff
Nephron|January 1, 1997
Creatine kinase subform analysis in hemodialysis patients without acute coronary syndromesM J Robbins, E M Epstein, S Shah
JAMA|November 4, 1992
Rates of avoidable hospitalization by insurance status in Massachusetts and MarylandJ S Weissman, C Gatsonis, A M Epstein
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1985
Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstrictionR Loutzenhiser, M Epstein, C Horton, et al.
American Journal of Nephrology|January 1, 1989
Relationship between plasma ANF responsiveness and renal sodium handling in cirrhotic humansM Epstein, R Loutzenhiser, P Norsk, et al.
Pageof 187

Showing results (471-480 of 1,865) with videos related to

Sort By:
Pageof 187
The New England Journal of Medicine|October 24, 2002
A series on patient safetyLucian Leape, Arnold M Epstein, Mary Beth Hamel
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 2, 2011
Disseminated malignancies masquerading as cardiovascular implantable electronic devices infectionsPipin Kojodjojo, Roy M John, Laurence M Epstein
Postgraduate Medicine|February 26, 2000
Hypertension in patients with diabetes. Why is aggressive treatment essential?G Bakris, J Sowers, M Epstein, et al.
Hypertension (Dallas, Tex. : 1979)|April 17, 2001
Diabetes, hypertension, and cardiovascular disease: an updateJ R Sowers, M Epstein, E D Frohlich
Biochemistry|November 25, 1980
Calorimetric studies of ligand-induced modulation of calcium adenosine 5'-triphosphatase from sarcoplasmic reticulumM Epstein, Y Kuriki, R Biltonen, et al.
The American Journal of Medicine|August 1, 1984
Physician beliefs, attitudes, and prescribing behavior for anti-inflammatory drugsA M Epstein, J L Read, R Winickoff
Nephron|January 1, 1997
Creatine kinase subform analysis in hemodialysis patients without acute coronary syndromesM J Robbins, E M Epstein, S Shah
JAMA|November 4, 1992
Rates of avoidable hospitalization by insurance status in Massachusetts and MarylandJ S Weissman, C Gatsonis, A M Epstein
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1985
Reversal by the calcium antagonist nisoldipine of norepinephrine-induced reduction of GFR: evidence for preferential antagonism of preglomerular vasoconstrictionR Loutzenhiser, M Epstein, C Horton, et al.
American Journal of Nephrology|January 1, 1989
Relationship between plasma ANF responsiveness and renal sodium handling in cirrhotic humansM Epstein, R Loutzenhiser, P Norsk, et al.
Pageof 187